相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence
Eugen Dhimolea et al.
CANCER CELL (2021)
Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy
Sumaiyah K. Rehman et al.
CELL (2021)
B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity
Baihao Zhang et al.
NATURE (2021)
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma
Oskar Marin-Bejar et al.
CANCER CELL (2021)
Regulation of Immune Functions by Non-Neuronal Acetylcholine (ACh) via Muscarinic and Nicotinic ACh Receptors
Masato Mashimo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cycling cancer persister cells arise from lineages with distinct programs
Yaara Oren et al.
NATURE (2021)
Neurotransmitters: emerging targets in cancer
Shu-Heng Jiang et al.
ONCOGENE (2020)
The great escape: tumour cell plasticity in resistance to targeted therapy
Soufiane Boumahdi et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway
Kari J. Kurppa et al.
CANCER CELL (2020)
Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma
Min-Wei Yang et al.
CANCER RESEARCH (2020)
Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression
Mong-Lien Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation
Shensi Shen et al.
CELL REPORTS (2020)
Persistent Cancer Cells: The Deadly Survivors
Shensi Shen et al.
CELL (2020)
Acetylcholine signaling system in progression of lung cancers
Jamie R. Friedman et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Choline acetyltransferase-expressing T cells are required to control chronic viral infection
Maureen A. Cox et al.
SCIENCE (2019)
Progenitors from the central nervous system drive neurogenesis in cancer
Philippe Mauffrey et al.
NATURE (2019)
LLGL2 rescues nutrient stress by promoting leucine uptake in ER+ breast cancer
Yasuhiro Saito et al.
NATURE (2019)
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
Gloria V. Echeverria et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Dietary methionine influences therapy in mouse cancer models and alters human metabolism
Xia Gao et al.
NATURE (2019)
Chronic nicotine exposure affects programmed death-ligand 1 expression and sensitivity to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer
Chang Dong Yeo et al.
TRANSLATIONAL CANCER RESEARCH (2019)
Electrical and synaptic integration of glioma into neural circuits
Humsa S. Venkatesh et al.
NATURE (2019)
Glutamatergic synaptic input to glioma cells drives brain tumour progression
Varun Venkataramani et al.
NATURE (2019)
Synaptic proximity enables NMDAR signalling to promote brain metastasis
Qiqun Zeng et al.
NATURE (2019)
Adaptive mutability of colorectal cancers in response to targeted therapies
Mariangela Russo et al.
SCIENCE (2019)
Acetylcholine receptors: Key players in cancer development
Jiawei Chen et al.
SURGICAL ONCOLOGY-OXFORD (2019)
CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies
William W. Feng et al.
CELL REPORTS (2019)
Alternative mRNA splicing in cancer immunotherapy
Luke Frankiw et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Toward Minimal Residual Disease-Directed Therapy in Melanoma
Florian Rambow et al.
CELL (2018)
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+Breast Cancer Subtypes
Spencer S. Watson et al.
CELL SYSTEMS (2018)
Histidine catabolism is a major determinant of methotrexate sensitivity
Naama Kanarek et al.
NATURE (2018)
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
Benjamin D. Hopkins et al.
NATURE (2018)
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
Rajeswara Rao Arasada et al.
NATURE COMMUNICATIONS (2018)
β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer (vol 33, pg 75, 2018)
Bernhard W. Renz et al.
CANCER CELL (2018)
A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition
Brian Biehs et al.
NATURE (2018)
A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy
Adriana Sanchez-Danes et al.
NATURE (2018)
Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages
Toszka Bohn et al.
NATURE IMMUNOLOGY (2018)
Targeting minimal residual disease: a path to cure?
Marlise R. Luskin et al.
NATURE REVIEWS CANCER (2018)
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy
Nicole Glodde et al.
IMMUNITY (2017)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer et al.
NATURE (2017)
Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation
Huangfei Yu et al.
SCIENTIFIC REPORTS (2017)
Understanding and targeting resistance mechanisms in NSCLC
Julia Rotow et al.
NATURE REVIEWS CANCER (2017)
Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure
Gulfem Dilek Guler et al.
CANCER CELL (2017)
Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling
Yoku Hayakawa et al.
CANCER CELL (2017)
MicroRNA-21 modulates radiation resistance through upregulation of hypoxia-inducible factor-1α-promoted glycolysis in non-small cell lung cancer cells
Shumei Jiang et al.
MOLECULAR MEDICINE REPORTS (2016)
Blood pressure regulation by CD4+ lymphocytes expressing choline acetyltransferase
Peder S. Olofsson et al.
NATURE BIOTECHNOLOGY (2016)
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
Maia Vinogradova et al.
NATURE CHEMICAL BIOLOGY (2016)
Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
Michael Ramirez et al.
NATURE COMMUNICATIONS (2016)
Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
Eishu Hirata et al.
CANCER CELL (2015)
Alternative Wnt Signaling Activates YAP/TAZ
Hyun Woo Park et al.
CELL (2015)
Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model
Heyan Li et al.
LUNG CANCER (2015)
YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers
Giorgio G. Galli et al.
MOLECULAR CELL (2015)
YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers
Claudia Stein et al.
PLOS GENETICS (2015)
The emerging roles of YAP and TAZ in cancer
Toshiro Moroishi et al.
NATURE REVIEWS CANCER (2015)
Cross-talk between Wnt/β-catenin and Hippo signaling pathways: a brief review
Minseong Kim et al.
BMB REPORTS (2014)
The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
Debasish Raha et al.
CANCER RESEARCH (2014)
YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response
Luca Azzolin et al.
CELL (2014)
Cholinergic Receptors as Target for Cancer Therapy in a Systems Medicine Perspective
P. Russo et al.
CURRENT MOLECULAR MEDICINE (2014)
Can we safely target the WNT pathway?
Michael Kahn
NATURE REVIEWS DRUG DISCOVERY (2014)
Hijacking the Neuronal NMDAR Signaling Circuit to Promote Tumor Growth and Invasion
Leanne Li et al.
CELL (2013)
Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor-Mediated Activation in PC9 Cells
Shuo Wang et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Restriction of intestinal stem cell expansion and the regenerative response by YAP
Evan R. Barry et al.
NATURE (2013)
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Jun Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
Yu Sun et al.
NATURE MEDICINE (2012)
Acetylcholinesterase, a Key Prognostic Predictor for Hepatocellular Carcinoma, Suppresses Cell Growth and Induces Chemosensitization
Yingjun Zhao et al.
HEPATOLOGY (2011)
Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit
Mauricio Rosas-Ballina et al.
SCIENCE (2011)
Choline metabolism in malignant transformation
Kristine Glunde et al.
NATURE REVIEWS CANCER (2011)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans
I. Wessler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Activated cholinergic signaling provides a target in squamous cell lung carcinoma
Pingfang Song et al.
CANCER RESEARCH (2008)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis
X. Li et al.
ONCOGENE (2008)
M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion
Pingfang Song et al.
CANCER RESEARCH (2007)
The clinical pharmacokinetics of darifenacin
A Skerjanec
CLINICAL PHARMACOKINETICS (2006)
分享论文
